44|103|Public
50|$|It is also {{approved}} for adjunctive therapy for epilepsy {{in patients who}} have not responded to first-line drugs and in children who are refractory to first-line drugs. It is not recommended for use in {{children between the ages}} of six months and three years, unless there is a compelling need. In addition to epilepsy and severe anxiety, clobazam is also approved as a short-term (2-4 weeks) <b>adjunctive</b> <b>agent</b> in schizophrenia and other psychotic disorders to manage anxiety or agitation.|$|E
40|$|Donor‐derived infections with multidrug‐resistant gram‐negative {{bacteria}} {{are associated with}} poor outcomes, {{in part because of}} limited treatment options. Here, we describe a case of donor‐derived, disseminated infection with colistin‐resistant, carbapenemase‐producing Klebsiella pneumoniae in a liver transplant recipient that was cured with addition of intravenous fosfomycin to a multidrug regimen, in conjunction with aggressive surgical source control. Intravenous fosfomycin represents a promising <b>adjunctive</b> <b>agent</b> for use in treatment of extensively drug‐resistant infections in immunocompromised hosts...|$|E
40|$|We {{demonstrated}} that a 2 % suspension of Pseudomonas aeruginosa alginate completely blocked {{the diffusion of}} gentamicin and tobramycin, but not that of carbenicillin, illustrating how alginate production can help protect P. aeruginosa growing within alginate microcolonies in patients with cystic fibrosis (CF) {{from the effects of}} aminoglycosides. This aminoglycoside diffusion barrier was degraded with a semipurified preparation of P. aeruginosa alginate lyase, suggesting that this enzyme deserves consideration as an <b>adjunctive</b> <b>agent</b> for CF patients colonized by mucoid strains of P. aeruginosa...|$|E
2500|$|In non-psychotic major {{depressive}} disorder (MDD) several SGAs {{have demonstrated}} significant efficacy as <b>adjunctive</b> <b>agents,</b> such agents include: ...|$|R
40|$|Substantial {{proportions}} of pa-tients with schizophrenia do not achieve acceptable levels of re-sponse with antipsychotic therapy alone, which commonly leads clinicians to use additional somatic interventions. This article reviews {{the literature on}} the use of adjunctive pharmacological treatments and electroconvulsive therapy (ECT) in schizophrenia. The authors find that, despite a large volume of literature, it is difficult to draw conclusions or treatment recommendations from available data because of small sample sizes and widely diver-gent study designs. At present, there is little firm evidence that adding <b>adjunctive</b> <b>agents</b> to standard neuroleptics will dra-matically change the somatic treatment of schizophrenia. The most promising <b>adjunctive</b> <b>agents</b> are benzodiazepines, lithium, and carbamazepine, as well as anti-depressants and ECT for affec-tive symptoms. Future inpatient research on adjunctive treatments should be multicenter studies, followed by long-term outpatient trials that assess quality-of-Iife issues as well as symptom relief...|$|R
40|$|This review {{provides}} {{an update on}} the pharmacology of airway management, emphasizing medications and management strategies widely used in an intensive care unit setting. Induction agents, muscle relaxants, opioids, sedative-hypnotics, and <b>adjunctive</b> <b>agents</b> are reviewed in the context of emergent airway management. Throughout this review, we emphasize the utility of considering a broad set of pharmacologic agents and approaches for airway management of the critically ill patient...|$|R
30|$|The {{association}} of biomaterial combined with repair factor-like platelet-rich plasma (PRP) has prospective values. Bovine-derived xenograft {{has been identified}} as an osteoconductive and biocompatible grafting material that provides osseointegration ability. PRP has become a valuable <b>adjunctive</b> <b>agent</b> to promote healing in a lot of dental and oral surgery procedures. However, there are controversies with respect to the regenerative capacity of PRP and the real benefits of its use in bone grafts. The {{purpose of this study was}} to assess the influence of PRP combined with xenograft for the repair of peri-implant bone defects.|$|E
40|$|For most {{patients}} with chronic kidney failure, kidney transplantation has the greatest potential for restoring a healthy and productive life. The risk of acute rejection is {{the highest in the}} first months after transplantation (induction phase) and diminishes afterwards (maintenance phase). Immunosuppression should be at the highest level in the early period and reduced for long-term therapy. At present, conventional immunosuppressive protocols consist of the triple therapy: a calcineurin inhibitor, an <b>adjunctive</b> <b>agent,</b> corticosteroids. The development of new immunosuppressives drugs is aimed not only at improving short-term outcomes, but also achieving better safety, less nephrotoxicity and minimal side effects...|$|E
40|$|Nodakenin, {{derived from}} the roots of Angelica gigas Nakai, is an {{important}} natural resource and medicinal material with anti-allergic and anti-inflammatory activities. We have previously shown that nodakenin inhibits IgE/Ag-induced degranulation in mast cells. In this study, we investigated the inhibitory effect of nodakenin on 2, 4 -dinitrochloro-benzene (DNCB) -induced atopic dermatitis (AD) -like skin lesions in ICR mice. Scratching behavior, skin severity score, blood IgE level, and skin thickness were improved in DNCB-induced AD-like ICR mice. Our results showed that nodakenin suppressed the increase of AD-like skin lesions in ICR mice. These results suggest that nodakenin may be a potential therapeutic resource for AD {{as well as an}} <b>adjunctive</b> <b>agent</b> to control itching associated with AD...|$|E
30|$|This {{study has}} {{important}} implications for practice and future research. Regardless of the patients’ CA dose, the association between low lactate concentration and hemodynamic response with AVP suggests that this marker of “less severe septic shock” is a useful indicator for AVP initiation. Furthermore, because of the improved outcomes in patients who had a positive hemodynamic response to AVP at 6  h, monitoring for the achievement of hemodynamic stability can be an important early warning sign for the bedside clinician. Specifically, in patients who do not achieve hemodynamic stability within 6  h of starting AVP, alternative therapeutic interventions such as epinephrine [32], corticosteroids [33, 34], angiotensin II [35] (if available), or increasing AVP dose (especially when NE requirements exceed 0.6 mcg/kg/min) [36] should be considered. The use of this trigger and the next best step should be further investigated. Future trials should incorporate the observed factors associated with AVP response into their design, which may improve their likelihood of finding a target population for AVP use. Additionally, trials should evaluate when to initiate additional <b>adjunctive</b> <b>agents</b> and also compare efficacy between <b>adjunctive</b> <b>agents.</b>|$|R
40|$|Advances in the {{surgical}} instrumentation and vitreoretinal techniques have allowed intraoperative reapproximation of retina {{to a more}} normal position. The use of intravitreally injected liquid materials (viscoelastic liquids, liquid perfluorocarbons and silicone oil), as <b>adjunctive</b> <b>agents</b> to vitreo-retinal surgery {{play an important role}} in facilitating retinal reattachment. These materials are used as intraoperative instruments to re-establish intraocular volume, assist in separating membranes adherent to the retina, manipulate retinal detachments and mechanically flatten detached retina. Over the longer term, silicone oil maintains intraocular tamponade. One should be cognizant of the potential uses, benefits and risks of each of these vitreous substitutes...|$|R
40|$|Regional {{anaesthesia}} has advantages such as, {{control of}} postoperative pain, early mobilization, {{and does not}} affect respiratory function. In recent years, regional anaesthesia had improved by {{the application of the}} peripheral nerve stimulator and ultrasound guided blocks, new local anaesthetic drugs with the use of additional <b>adjunctive</b> <b>agents.</b> Especially in emergency conditions, combination of regional anaesthesia may avoid the complications of general anesthesia in patients with chronic disease who suffer from upper and lower extremity injuries. In this paper, we present two cases who underwent combined regional anaesthesia techniques for the lower and upper extremity surgery...|$|R
40|$|In {{the last}} decade, {{numerous}} novel ocular hypotensive agents {{have been introduced}} for the control of intraocular pressure (IOP). Clinicians now have more options than ever {{in the selection of}} medical therapy for the treatment of glaucoma and ocular hypertension. When selecting an ocular hypotensive medication for their patients, clinicians should consider not only the IOP-lowering efficacy of an agent, but also the ability of the drug to allow patients to achieve target levels of IOP that are low enough to stop the progression of glaucomatous damage. Other considerations should include how well the drug controls diurnal IOP, the likelihood of serious adverse events, the versatility of the medication for use as an <b>adjunctive</b> <b>agent,</b> as well as other potential attributes (ie, neuroprotection) ...|$|E
40|$|Disulfiram is an {{aldehyde}} dehydrogenase inhibitor that {{is widely used}} as an <b>adjunctive</b> <b>agent</b> {{in the treatment of}} patients with severe chronic alcoholism. Recent positron emission tomography (PET) studies of local cerebral metabolic rates for glucose (ICMRglc) and benzodiazepine receptor binding in alcoholic patients have shown regional cerebral abnormalities; however, some of the patients were studied while receiving disulfiram, which could influence the bio-chemical processes under investigation. In a retrospective investi-gation, we examined the influence of disulfiram administration on the results of PET studies of ICMRglc and benzodiazepine receptor bind-ing and neuropsychological tests of cognition and executive function in patients with severe chronic alcoholism. [' 8 F]Fluorodeoxyglucose was used to measure ICMRglc in 48 male patients, including 11 re-ceiving and 37 not receiving disulfiram in therapeutic doses. ["C]Flumazenil was used to measure benzodiazepine receptor bind...|$|E
40|$|Cyclosporine was {{introduced}} into clinical practice in thelate 1970 s, {{resulting in a}} dramatic increase in 1 -year graft survival rates. However, its current use has been limit-ed by severe nephrotoxic events. 1 - 3 Recently, the availability of tacrolimus has provided a new option for many practi-tioners. In many cases, tacrolimus replaces cyclosporine as a primary immunosuppressant agent in liver and kidney transplant regimens because of predictable serum drug con-centrations with fewer subtherapeutic concentrations. 3 Tacrolimus displays several limiting toxicities similar to those of cyclosporine, in particular, nephrotoxicity and neu-rotoxicity; therefore, tacrolimus may not be a viable option for some patients. 4 Sirolimus is a potent immunosuppres-sant used as an <b>adjunctive</b> <b>agent</b> in transplant regimens to limit the daily doses of cyclosporine and corticosteroids and lower the incidence of adverse effects associated with thei...|$|E
30|$|The {{treatment}} of peri-implantitis {{in the case}} of incipient bone loss involves the elimination of local irritants with or without surface decontamination, systemic antibiotics, some additional <b>adjunctive</b> therapies <b>agents</b> or devices (Machtei 2014).|$|R
40|$|Anticonvulsant {{medications}} such as phenytoin, carba-mazepine, and {{valproic acid}} are common <b>adjunctive</b> <b>agents</b> {{in the treatment}} of HIV-infected patients. The inci-dence of seizures may be as high as 11 % in this popula-tion. 1 - 3 This elevated seizure rate is secondary to neurolog-ic manifestations of HIV and opportunistic infections such as central nervous system (CNS) tuberculosis, toxoplas-mosis, cryptococcosis, CNS lymphoma, and HIV demen-tia. 1, 2, 4 Anticonvulsant use has also risen due to expanded indications for treatment of neuralgias, refractory headaches, depression, and bipolar disorder. Patients treated with a combination of anticonvulsants and antiretroviral agents are at increased risk of interactions. Many first-generation anticonvulsants (eg, phenytoin, carbamazepine, phenobar-bital) are metabolized by the cytochrome P 450 enzym...|$|R
40|$|In {{oncology}} {{patients who}} undergo {{positron emission tomography}} (PET) /computed tomography (CT), radiolabeled [18 F]- 2 -fluoro- 2 -deoxy-D-glucose (FDG) is utilized to obtain qualitative and quantitative data about tumour metabolism. The process of patient preparation before FDG-PET/CT imaging (scanning) primarily includes acquisition of patient data, fasting before imaging, regulation of blood glucose and insulin levels, administration of FDG and radiologic contrast material, administration of <b>adjunctive</b> <b>agents,</b> scheduling of the imaging in recently treated patients, imaging during pregnancy and lactation, and final arrangements before imaging. Standardization of procedures for patient preparation in oncological FDG-PET/CT imaging is extremely important to obtain high-quality images, to decrease false-negative and false-positive findings and to reduce the patient radiation dose as much as possible...|$|R
40|$|In {{comparison}} to polyethylene glycol, lubiprostone offers other advantages and is increasingly {{being used as}} an <b>adjunctive</b> <b>agent</b> in diagnostic as well as management strategies not only in gastroenterology, but in other fields. For instance, lubiprostone exerts beneficial effects in cystic fibrosis tissues. It augmernts the chloride secretion in these cells by activating non-cystic fibrosis transmembrane regulator (CFTR) secretion of chloride by afflicted respiratory epithelia. Lubiprostone also seems to improve visualization of the gastrointestinal tract during procedures such as colonoscopy. This is especially true if the lubiprostone is administered prior to bowel cleansing with agents such as polyethylene glycol electrolyte (PEG-E). Lubiprostone also enhances and stimulates contraction in colonic as well as gastric muscles and may thus further contribute as a prokinetic agent. Besides these effects, lubiprostone also causes hyperpolarization in other tissues such as uterine muscle cells. This {{may prove to be}} of significant clinical benefit in the management of uterine pathologies in the near future...|$|E
40|$|Nicotinamide adenine {{dinucleotide}} phosphate (NADPH) oxidase (NOX) {{was originally}} identified in immune cells as playing an important microbicidal role. In stroke and cerebrovascular disease, inflammation is increasingly being recognized as contributing negatively to neurological outcome, with NOX {{as an important}} source of superoxide. Several labs have now shown that blocking or deleting NOX in the experimental stroke models protects from brain ischemia. Recent work has implicated glucose as an important NOX substrate leading to reperfusion injury, and that NOX inhibition can improve the detrimental effects of hyperglycemia on stroke. NOX inhibition also appears to ameliorate complications of thrombolytic therapy by reducing blood-brain barrier disruption, edema formation, and hemorrhage. Further, NOX from circulating inflammatory cells seems to contribute more to ischemic injury more than NOX generated from endogenous brain residential cells. Several pharmacological inhibitors of NOX are now available. Thus, blocking NOX activation may prove to be a promising treatment for stroke as well as an <b>adjunctive</b> <b>agent</b> to prevent its secondary complications. © W. S. Maney & Son Ltd 2012...|$|E
40|$|Cyclosporine is an {{immunosuppressive}} agent that displays a broad intra- and inter-individual pharmacokinetic variability. To evaluate the factors, which significantly influence cyclos-porine blood levels in our renal transplant recipients, we studied 611 consecutive patients trans-planted from living donors in Baqiyatallah hospital, Tehran, Iran from 1984 to 2005. The patients {{were divided into}} two groups: Group I included patients treated with mycophenolate sodium (MS) as an adjunctive {{immunosuppressive agent}} and Group II treated with azathioprine (AZA) as an <b>adjunctive</b> <b>agent.</b> Measurements of cyclosporine blood tough levels (C 0) were performed 12 hours after the morning dose (just before the night dose). The mean age of the study population at time of transplantation was 38. 7 &# 177; 13. 7 years and males formed 67 &#x 0025; of it. Univariate analysis and multi-variable linear regression model showed that older age at transplantation, treatment with MS, and time interval from time of transplantation were significantly related with higher C 0 levels. We conclude that there is an interaction of immunosuppressive agents in renal transplant patients with higher cyclosporine levels in the recipients of MS...|$|E
40|$|Modern {{immunosuppressive}} regimens {{reduce the}} acute rejection rate by combining a cornerstone immunosuppressant like tacrolimus or cyclosporine with <b>adjunctive</b> <b>agents</b> like corticosteroids, mycophenolate mofetil (MMF) or azathioprine, {{often associated with}} untoward side effects. A 6 -month randomized {{study was conducted in}} 47 European centers. Triple therapy with tacrolimus (trough levels 5 – 15 ng/mL), corticosteroids (dosage 10 mg/day) and MMF (1 g/day) was administered for 3 months. From day 92, patients either continued with triple therapy (control, n = 277), or stopped steroids (n = 279), or stopped MMF (n = 277). Surrogate markers for long-term benefits were changes in lipid profiles and occurrence of hematological, gastrointestinal and infectious complications. The 6 -month acute rejection incidence (biopsy-proven) was similar in all groups (17. 0...|$|R
40|$|Periodontitis is a {{ubiquitous}} and irreversible inflammatory {{condition and}} represents a significant public health burden. Severe periodontitis affects over 11 % of adults, {{is a major}} cause of tooth loss impacting negatively upon speech, nutrition, quality of life and self-esteem, and has systemic inflammatory consequences. Periodontitis is preventable and treatment leads to reduced rates of tooth loss and improved quality of life. However, successful treatment necessitates behaviour change in patients to address lifestyle risk factors (e. g. smoking) and, most importantly, to attain and sustain high standards of daily plaque removal, lifelong. While mechanical plaque removal remains the bedrock of successful periodontal disease management, in high-risk patients it appears that the critical threshold for plaque accumulation to trigger periodontitis is low, and such patients may benefit from <b>adjunctive</b> <b>agents</b> for primary prevention of periodontitis. status: publishe...|$|R
40|$|Negative {{symptoms}} of schizophrenia remain {{an area of}} substantial unmet clinical need. By convening a consensus conference in January 2005, the NIMH has taken {{a leading role in}} stimulating a resurgence of interest in methodological considerations related to development of new medications for treating negative symptoms. One audience for this work is clinical researchers in industry. They must take ideas, like those emerging from this consensus meeting, and determine whether they can be applied to their global trials {{in order to meet the}} needs of a broad group of customers, which include patients, clinicians, regulators, and payers. This article takes the ideas that surfaced from the NIMH consensus work and interprets them in terms of issues that industry faces for its clinical trials. Particular emphasis is given to addressing hurdles to study design and analysis that come when developing broad-spectrum or <b>adjunctive</b> <b>agents</b> that may be effective for negative symptoms...|$|R
40|$|This {{case report}} {{summarizes}} the {{first use of}} intravenous vitamin C employed as an adjunctive interventional agent in the therapy of recurrent acute respiratory distress syndrome (ARDS). The two episodes of ARDS occurred in a young female patient with Cronkhite-Canada syndrome, a rare, sporadically occurring, noninherited disorder that is characterized by extensive gastrointestinal polyposis and malabsorption. Prior to the episodes of sepsis, the patient was receiving nutrition via chronic hyperalimentation administered through a long-standing central venous catheter. The patient became recurrently septic with Gram positive cocci which led to two instances of ARDS. This report describes the broad-based general critical care of a septic patient with acute respiratory failure that includes fluid resuscitation, broad-spectrum antibiotics, and vasopressor support. Intravenous vitamin C infused at 50 [*]mg per kilogram body weight every 6 hours for 96 hours was incorporated as an <b>adjunctive</b> <b>agent</b> {{in the care of}} this patient. Vitamin C when used as a parenteral agent in high doses acts “pleiotropically” to attenuate proinflammatory mediator expression, to improve alveolar fluid clearance, and to act as an antioxidant...|$|E
40|$|Recent {{reports of}} reduced {{response}} to standard therapies for Clostridium difficile infection (CDI) {{and the risk}} for recurrent CDI that is common with all currently available treatment agents have posed a significant chal-lenge to clinicians. Current recommendations include metronidazole for treatment of mild to moderate CDI and vancomycin for severe CDI. Results from small clinical trials suggest that nitazoxanide and teicoplanin may be alternative options to standard therapies, whereas rifaximin has demonstrated success in uncontrolled trials {{for the management of}} multiple recurrences. Anecdotal reports have also suggested that tigecycline might be useful as an <b>adjunctive</b> <b>agent</b> for the treatment of severe complicated CDI. Reports of resistance will likely limit the clinical use of fusidic acid and bacitracin and, possibly, rifaximin if resistance to this agent becomes widespread. Treatment of patients with multiple CDI recurrences and those with severe complicated CDI is based on limited clinical evidence, and new treatments or strategies are needed. Ten to 20 years ago, there was little interest in devel-oping new treatment agents for Clostridium difficile infection (CDI) because CDI in most patients responded to metronidazole or vancomycin therapy, recurrent disease was common but more easil...|$|E
40|$|Efficacy of {{chemotherapy}} {{in advanced stages}} of colorectal tumours is limited. The quinolone antibiotic ciprofloxacin was recently shown to inhibit growth and to induce apoptosis in human bladder carcinomas cells. We investigated the effect of ciprofloxacin on colon carcinoma lines in vitro. CC- 531, SW- 403 and HT- 29 colon carcinoma and HepG 2 hepatoma cells (control cells) were exposed to ciprofloxacin. Proliferation was assessed by bromodeoxyuridine-incorporation into DNA and apoptosis was measured by flow cytometry after propidium iodide or JC- 1 staining. Expression of anti-apoptotic Bcl- 2 and pro-apoptotic Bax was analyzed by semiquantitative Western blot analysis and activity of caspases 3, 8 and 9 by substrate-cleavage assays. Ciprofloxacin suppressed DNA synthesis of all colon carcinoma cells time- and dose-dependently, whereas the hepatoma cells remained unaffected. Apoptosis reached its maximum between 200 and 500 [*]μg[*]ml− 1. This was accompanied by an upregulation of Bax and of the activity of caspases 3, 8 and 9, and paralleled by a decrease of the mitochondrial membrane potential. Ciprofloxacin decreases proliferation and induces apoptosis of colon carcinoma cells, possibly in part by blocking mitochondrial DNA synthesis. Therefore, qualification of ciprofloxacin as <b>adjunctive</b> <b>agent</b> for colorectal cancer should be evaluated...|$|E
40|$|One {{important}} aspect of photomedicine {{is the use of}} nonionizing electromagnetic radiation with and without exogenous photosensitizers to treat diseases. Phototoxicity (cell injury by photons) is a likely mechanism for phototherapy and photochemotherapy of several skin diseases. The mechanism of action for phototherapy of hyperbilirubinemia and of uremic pruritus appears to be photochemical alteration of extracellular inetabolites. Psoriasis {{is an example of a}} disease benefitted by several forms of phototherapy and photocheinotherapy with varying relative effectiveness and safety. Two successful forms of treatment are oral psoralen photochemotherapy and UVB plus topical <b>adjunctive</b> <b>agents.</b> New information about UVB therapy of psoriasis includes data about the therapeutic action spectrum and about the relative roles of various topical agents such as coal tar, mineral oil, “lubricants” and steroids. Although there are many surface similarities, phototherapy and psoralen photochemotherapy have fundamental differences which may alter longterm risks in quantitative and qualitative ways...|$|R
40|$|In this article, {{we review}} the {{literature}} on practice effects in schizophrenia, an underappreciated confound in interpreting cognitive improvement in clinical trials. We first examine claims regarding first- and second-generation antipsychotic medications as cognitive enhancers, and follow it {{with a discussion of}} recent studies demonstrating how practice or placebo effects may drive ‘positive' findings. Thus, this review suggests that many previous findings can be reinterpreted in this light. Critically, we also make several suggestions about test construction, study design, and statistical analyses that the field might use to overcome this potential confound. Our suggestions may also have implications for drug discovery and regulatory approval of cognitive-enhancing <b>adjunctive</b> <b>agents,</b> in terms of study design and/or test psychometric characteristics, including the development of tests that are relatively insensitive to practice-related changes. Such advances might be important for improving the methodology involved in the assessment of cognitive change in treatment studies...|$|R
40|$|Kidney {{involvement}} with progressive loss of kidney function (Fabry nephropathy) {{is an important}} complication of Fabry disease, an X-linked lysosomal storage disorder arising from deficiency of α-galactosidase activity. Clinical trials have shown that enzyme replacement therapy (ERT) with recombinant human α-galactosidase clears globotriaosylceramide from kidney cells, and can stabilize kidney function in patients with mild to moderate Fabry nephropathy. Recent trials show that patients with more advanced Fabry nephropathy and overt proteinuria do not respond as well to ERT alone, but can benefit from anti-proteinuric therapy given in conjunction with ERT. This review focuses {{on the use of}} enzyme replacement therapy with agalsidase-alfa and agalsidase-beta in adults with Fabry nephropathy. The current results are reviewed and evaluated. The issues of dosing of enzyme replacement therapy, the use of <b>adjunctive</b> <b>agents</b> to control urinary protein excretion, and the individual factors that affect disease severity are reviewed...|$|R
40|$|The mucosal protein {{lactoferrin}} (LF) {{reduces the}} MIC of vancomycin for staphylococcal isolates sensitive to this glycopeptide. The {{purpose of this}} research was to investigate the effect of LF on the MIC of vancomycin for vanB resistant isolates of Enterococcusfaecalis (Efs 1) and E. faecium (Efm 1). At a concentration of 2048 μg/ml, LF reduced the MIC of vancomycin 16 -fold for Efs 1 and eight-fold for Efm 1. The cell wall precursors of Efs 1 were examined following growth in media supplemented with LF, d-alanine or d-lactate. The precursors were extracted from harvested cells by ether and ion exchange chromatography and the amino acid and lactate composition was determined. Compared with that of unsupplemented media, d-alanine or LF supplementation caused an increase in the d-alanine content of the precursors. Concomitantly, the d-lactate content was reduced. Exogenous d-lactate did not affect the composition of the precursors. This suggests that LF caused an increase in the pool of pentapeptide cell wall precursors. The LF-induced reduction in the vancomycin resistance of enterococci at in vivo concentrations suggests a potential use for this protein as an <b>adjunctive</b> <b>agent</b> to vancomycin...|$|E
40|$|Silver {{nanoparticles}} {{have received}} considerable interest as new "nanoantibiotics" {{with the potential}} to kill drug-resistant microorganisms. Recently, a class of new core-shell nanostructures, Pd@Ag nanosheets (Pd@Ag NSs), were created using deposition techniques and demonstrated excellent inhibitory effects on various bacteria in vitro. In this study, we evaluated the antifungal activity of Pd@Ag NSs against common invasive fungal pathogens. Among these organisms, Cryptococcus neoformans complex species was most susceptible to Pd@Ag NSs, which exhibited potent antifungal activity against various molecular types or sources of cryptococcal strains including fluconazole-resistant isolates. The anticryptococcal activity of Pd@Ag NSs was significantly greater than fluconazole and similar to that of amphotericin B (AmB). At relatively high concentrations, Pd@Ag NSs exhibited fungicidal activity against Cryptococcus spp., which can likely be attributed to the disruption of cell integrity, intracellular protein synthesis, and energy metabolism. Intriguingly, Pd@Ag NSs also exhibited strong synergistic anti-cryptococcal fungicidal effects at low concentrations in combination with AmB but exhibited much better safety in erythrocytes than AmB, even at the minimal fungicidal concentration. Therefore, Pd@Ag NSs may be a promising <b>adjunctive</b> <b>agent</b> for treating cryptococcosis, and further investigation for clinical applications is required...|$|E
30|$|Delirium is {{characterized}} by a disturbance of consciousness with accompanying change in cognition. Delirium typically manifests as a constellation of symptoms with an acute onset and a fluctuating course. Delirium is extremely common {{in the intensive care unit}} (ICU) especially amongst mechanically ventilated patients. Three subtypes have been recognized: hyperactive, hypoactive, and mixed. Delirium is frequently undiagnosed unless specific diagnostic instruments are used. The CAM-ICU is the most widely studied and validated diagnostic instrument. However, the accuracy of this tool may be less than ideal without adequate training of the providers applying it. The presence of delirium has important prognostic implications; in mechanically ventilated patients it is associated with a 2.5 -fold increase in short-term mortality and a 3.2 -fold increase in 6 -month mortality. Nonpharmacological approaches, such as physical and occupational therapy, decrease the duration of delirium and should be encouraged. Pharmacological treatment for delirium traditionally includes haloperidol; however, more data for haloperidol are needed given the paucity of placebo-controlled trials testing its efficacy to treat delirium in the ICU. Second-generation antipsychotics have emerged as an alternative for the treatment of delirium, and they may have a better safety profile. Dexmedetomidine may prove to be a valuable <b>adjunctive</b> <b>agent</b> for patients with delirium in the ICU.|$|E
40|$|OBJECTIVE: Inflammation {{has been}} implicated in the risk, pathophysiology, and {{progression}} of mood disorders and, as such, has become a target {{of interest in the}} treatment of bipolar disorder (BD). Therefore, the objective of the current qualitative and quantitative review was to determine the overall antidepressant effect of <b>adjunctive</b> anti-inflammatory <b>agents</b> in the treatment of bipolar depression. METHODS: Completed and ongoing clinical trials of anti-inflammatory agents for BD published prior to 15 May 15 2015 were identified through searching the PubMed, Embase, PsychINFO, and Clinicaltrials. gov databases. Data from randomized controlled trials (RCTs) assessing the antidepressant effect of adjunctive mechanistically diverse anti-inflammatory agents were pooled to determine standard mean differences (SMDs) compared with standard therapy alone. RESULTS: Ten RCTs were identified for qualitative review. Eight RCTs (n = 312) assessing adjunctive nonsteroidal anti-inflammatory drugs (n = 53), omega- 3 polyunsaturated fatty acids (n = 140), N-acetylcysteine (n = 76), and pioglitazone (n = 44) in the treatment of BD met the inclusion criteria for quantitative analysis. The overall effect size of <b>adjunctive</b> anti-inflammatory <b>agents</b> on depressive symptoms was - 0. 40 (95 % confidence interval - 0. 14 to - 0. 65, p = 0. 002), indicative of a moderate and statistically significant antidepressant effect. The heterogeneity of the pooled sample was low (I&sup 2; = 14 %, p = 0. 32). No manic/hypomanic induction or significant treatment-emergent adverse events were reported. CONCLUSIONS: Overall, a moderate antidepressant effect was observed for <b>adjunctive</b> anti-inflammatory <b>agents</b> compared with conventional therapy alone in the treatment of bipolar depression. The small number of studies, diversity of agents, and small sample sizes limited interpretation of the current analysis...|$|R
40|$|Systemic {{combination}} metronidazole and tetracycline were compare as <b>adjunctive</b> <b>agents</b> in {{the treatment}} of rapidly progressive periodontitis (RPP), 30 patients with RPP were treated with scaling and root planing, control of oral hygiene and periodontal surgery if indicated. The patients were randomly divided into 3 equal groups: the first group had metronidazole 200 mg x 3 x 10 days, and then to be continued with tetracycline 250 mg x 4 x 12 days. The second group had tetracycline 250 mg x 4 x 12 days and then to be continued with metronidazole 200 mg x 3 x 10 days. The third group as control received no medication. All the group had not periodontal surgery after received medications. Gingival Index (GI), Probing Depth (PD), Suppuration and Ginigival Bleeding after probing (GB) registered. All parameters were monitored at 10, 12, and 22 days after treatment. By the end of the research all groups showed improvement. In conclusion: treatment of RPP with tetracycline to be continued with metronidazole were more effective than metronidazole to be continued with tetracycline to produce better clinical results. </span...|$|R
40|$|AbstractBackgroundLonglasting and {{unbearable}} pain {{is the most}} common and striking symptom of chronic pancreatitis. Accordingly, pain relief and improvement in patients' quality of life are the primary goals in the treatment of this disease. This systematic review aims to summarize the available data on treatment options. MethodsA systematic search of MEDLINE/PubMed and the Cochrane Library was performed according to the PRISMA statement for reporting systematic reviews and meta-analysis. The search was limited to randomized controlled trials and meta-analyses. Reference lists were then hand-searched for additional relevant titles. The results obtained were examined individually by two independent investigators for further selection and data extraction. ResultsA total of 416 abstracts were reviewed, of which 367 were excluded because they were obviously irrelevant or represented overlapping studies. Consequently, 49 full-text articles were systematically reviewed. ConclusionsFirst-line medical options include the provision of pain medication, <b>adjunctive</b> <b>agents</b> and pancreatic enzymes, and abstinence from alcohol and tobacco. If medical treatment fails, endoscopic treatment offers pain relief in the majority of patients in the short term. However, current data suggest that surgical treatment seems to be superior to endoscopic intervention because it is significantly more effective and, especially, lasts longer...|$|R
